February 28, 2015 1:20 AM ET


Company Overview of Sirion Holdings, Inc.

Company Overview

Sirion Holdings, Inc., through its subsidiaries, engages in the research, discovery, development, and commercialization of pharmaceutical products and medical devices for the ophthalmic market. Its products are used to treat various sight threatening and debilitating eye diseases and conditions, including those that affect the back of the eye. The company offers ST-601, an ophthalmic steroid emulsion with indications for steroid responsive inflammatory ophthalmic diseases; ST-602, which is used to reduce the accumulation of toxic vitamin A derivatives, including lipofuscin in the eye by reducing the level of serum retinol; ST-603, a compound with the active ingredient cyclosporine-A that is ...

3110 Cherry Palm Drive

Suite 340

Tampa, FL 33619

United States

Founded in 2006

45 Employees





Key Executives for Sirion Holdings, Inc.

Co-Founder, Chairman, Chief Executive Officer and President
Age: 54
Co-Founder, Chief Medical Officer and Director
Age: 70
Co-Founder and Chief Commercial Officer
Age: 49
Co-Founder and Chief Business Officer
Age: 65
Senior Vice President of Finance
Age: 46
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Scholar Rock, Inc. United States
Cary Pharmaceuticals Inc. United States
PPD Vaccines and Biologics, LLC United States
PrinJohnson BioPharm, Inc. United States
Particle Dynamics, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sirion Holdings, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.